SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Halina White, Neurologic Manifestations of Acute and Chronic Liver Disease, CONTINUUM: Lifelong Learning in Neurology, 2014, 20, 670

    CrossRef

  2. 2
    Adrian Budhram, Clara Cebrian, Paranoid psychosis and cognitive impairment associated with hepatitis C antiviral therapy, General Hospital Psychiatry, 2014, 36, 1, 126.e3

    CrossRef

  3. 3
    Kosuke Kajitani, Shigenobu Kanba, Escitalopram Ameliorates Prolonged Depression With Psychotic Features Induced by Interferon Therapy for Hepatitis C Infection: Report of 2 Cases, Psychosomatics, 2013, 54, 5, 506

    CrossRef

  4. 4
    Sanjeev Sockalingam, Alice Tseng, Pierre Giguere, David Wong, Psychiatric treatment considerations with direct acting antivirals in hepatitis C, BMC Gastroenterology, 2013, 13, 1, 86

    CrossRef

  5. 5
    Martin Schaefer, Lucile Capuron, Astrid Friebe, Crisanto Diez-Quevedo, Geert Robaeys, Sergio Neri, Graham R. Foster, Achim Kautz, Daniel Forton, Carmine M. Pariante, Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statement, Journal of Hepatology, 2012, 57, 6, 1379

    CrossRef

  6. 6
    M. Peters, E. Wehking, Hepatitis C und ihre Auswirkungen auf das Gehirn, Trauma und Berufskrankheit, 2012, 14, 3, 208

    CrossRef

  7. 7
    Francis Lotrich, Inflammation, Interferon-Alpha, and Depression, Psychiatric Annals, 2012, 42, 9, 317

    CrossRef

  8. 8
    Marcia D McNutt, Shuling Liu, Amita Manatunga, Erica B Royster, Charles L Raison, Bobbi J Woolwine, Marina F Demetrashvili, Andrew H Miller, Dominique L Musselman, Neurobehavioral Effects of Interferon-α in Patients with Hepatitis-C: Symptom Dimensions and Responsiveness to Paroxetine, Neuropsychopharmacology, 2012, 37, 6, 1444

    CrossRef

  9. 9
    Aye-Mu Myint, Markus J. Schwarz, Norbert Müller, The role of the kynurenine metabolism in major depression, Journal of Neural Transmission, 2012, 119, 2, 245

    CrossRef

  10. 10
    S. Sockalingam, P. S. Links, S. E. Abbey, Suicide risk in hepatitis C and during interferon-alpha therapy: a review and clinical update, Journal of Viral Hepatitis, 2011, 18, 3
  11. 11
    Sanjeev Sockalingam, Susan E. Abbey, Fahad Alosaimi, Marta Novak, A Review of Sleep Disturbance in Hepatitis C, Journal of Clinical Gastroenterology, 2010, 44, 1, 38

    CrossRef

  12. 12
    Benjamin C. Silverman, Arthur Y. Kim, Oliver Freudenreich, Interferon-Induced Psychosis as a “Psychiatric Contraindication” to Hepatitis C Treatment: A Review and Case-Based Discussion, Psychosomatics, 2010, 51, 1, 1

    CrossRef

  13. 13
    Francis Lotrich, Management of Psychiatric Disease in Hepatitis C Treatment Candidates, Current Hepatitis Reports, 2010, 9, 2, 113

    CrossRef

  14. 14
    Meyler's Side Effects of Drugs in Cancer and Immunology, 2010,

    CrossRef

  15. 15
    Yi-Chun Cheng, Chun-Chih Chen, Ai-Sheng Ho, Nan-Ying Chiu, Prolonged Psychosis Associated With Interferon Therapy in a Patient With Hepatitis C: Case Study and Literature Review, Psychosomatics, 2009, 50, 5, 538

    CrossRef

  16. 16
    Rosa Quelhas, Alice Lopes, Psychiatric Problems in Patients Infected with Hepatitis C Before and During Antiviral Treatment with Interferon-Alpha: A Review, Journal of Psychiatric Practice, 2009, 15, 4, 262

    CrossRef

  17. 17
    Stéphane Schmitter, Jean-Philippe Lang, Laurent Michel, Laurent Castera, Psychiatrie, VIH et hépatite C, 2009,

    CrossRef

  18. 18
    Meyler's Side Effects of Psychiatric Drugs, 2009,

    CrossRef

  19. 19
    Hubert Weibel, Psychiatrie, VIH et hépatite C, 2009,

    CrossRef

  20. 20
    James H. Tabibian, Donna A. Wirshing, Joseph M. Pierre, Lisa H. Guzik, Michael D. Kisicki, Itai Danovitch, Shirley J. Mena, William C. Wirshing, Hepatitis B and C Among Veterans on a Psychiatric Ward, Digestive Diseases and Sciences, 2008, 53, 6, 1693

    CrossRef

  21. 21
    Cynthia M. A. Geppert, Sanjeev Arora, Widening the door: The evolution of hepatitis C treatment in patients with psychiatric disorders, Hepatology, 2007, 46, 4
  22. 22
    Lisa A. Mistler, Mary F. Brunette, Bryan J. Marsh, Robert M. Vidaver, Ravi Luckoor, Stanley D. Rosenberg, Hepatitis C Treatment for People With Severe Mental Illness, Psychosomatics, 2006, 47, 2, 93

    CrossRef

  23. 23
    Pamela DeRosse, Philip R. Szeszko, Anil K. Malhotra, Interferon-induced obsessive-compulsive disorder, General Hospital Psychiatry, 2006, 28, 4, 357

    CrossRef

  24. 24
    David Telio, Sanjeev Sockalingam, Vicky Stergiopoulos, Persistent Psychosis After Treatment With Interferon Alfa, Journal of Clinical Psychopharmacology, 2006, 26, 4, 446

    CrossRef

  25. 25
    Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions, 2006,

    CrossRef

  26. 26
    Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions, 2006,

    CrossRef

  27. 27
    CATHERINE CRONE, GEOFFREY M. GABRIEL, Comprehensive Review of Hepatitis C for Psychiatrists: Risks, Screening, Diagnosis, Treatment, and Interferon-Based Therapy Complications, Journal of Psychiatric Practice, 2003, 9, 2, 93

    CrossRef

  28. 28
    ALESSANDRO ROSSI, DANIELA RENZETTI, LUIGI D’ALBENZIO, DANIELA GIANFELICE, ARTEMIS KALYVOKA, OSVALDO RINALDI, Case of mania induced by withdrawal of interferon-α in a patient affected by bipolar disorder, Psychiatry and Clinical Neurosciences, 2002, 56, 6
  29. 29
    Thierry Vial, Jacques Descotes, 2002,

    CrossRef